.RESEARCH STUDY FEATURE.06 August 2024.
A sizable randomized regulated trial with cisgender girls highlights the challenges of adherence to a regular dental preexposure prophylaxis regiment as well as shows that twice-yearly treatment of lenacapavir may sustain helpful HIV avoidance degrees over 6 months.